Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
CD19和CD20靶向嵌合抗原受体T细胞联合治疗复发难治性弥漫性大B细胞淋巴瘤的II期临床试验
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3259
Sang, Wei; Shi, Ming; Yang, Jingjing; Cao, Jiang; Xu, Linyan; Yan, Dongmei; Yao, Meixue; Liu, Hui; Li, Weidong; Zhang, Bing; Sun, Kemeng; Song, Xuguang; Sun, Cai; Jiao, Jun; Qin, Yuanyuan; Sang, Tingting; Ma, Yuanyuan; Wu, Mei; Gao, Xiang; Cheng, Hai; Yan, Zhiling; Li, Depeng; Sun, Haiying; Zhu, Feng; Wang, Ying; Zeng, Lingyu; Li, Zhenyu; Zheng, Junnian; Xu, Kailin
B细胞
T细胞
信号转导
淋巴瘤
CD20
T细胞
细胞生物学
CD2
CD19
免疫/内分泌